Mirexus announces investment from Goddard Enterprises

2 minute read
01 April 2015

On April 10, 2015, Mirexus Biotechnologies Inc. announced a new investment from Goddard Enterprises Ltd. (“GEL”) of Barbados.

GEL will be investing US$3.5 million in equity financing as part of an investment consortium that will be supplying a total of at least US$3.7 million. Goddard contributed $2 million as of April 10, 2015 and will contribute an additional US$1.5 million within the next three years. The balance of funds are being provided by existing individual shareholders, originally sourced from the GreenSky Presidents Club, a federally licensed Angel Group managed by GreenSky Capital, Inc. of Toronto.

Mirexus Inc. is a safe and natural biomaterials company based in Guelph, Ontario that is commercializing a novel nanotechnology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health.

Gowlings advised Mirexus in the negotiation of this financing with a team that included David Pamenter and David Campbell (corporate/technology) and Carole Chouinard (tax).

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.